Verbatim response from Claude
This is a common situation, and compounded GLP-1s are worth considering, but here's a clear picture of your options:
Compounded Semaglutide Options
Hims/Hers, Ro (Body Program), and Henry Meds are reputable telehealth platforms offering compounded semaglutide. They typically run $200-$400/month, which is significantly less than Wegovy's list price.
Important caveats:
- Quality varies by compounding pharmacy
- FDA has raised some safety concerns about compounded versions
- These are not FDA-approved products
Other Options to Consider First
Appeal your denial - Many denials get overturned. Your doctor can submit a prior authorization appeal with documentation of medical necessity.
Manufacturer savings programs - Novo Nordisk's savings card can reduce Wegovy to around $650/month or sometimes less if you qualify.
Try Zepbound (tirzepatide) - Sometimes insurers cover one GLP-1 but not another. It's worth asking your doctor about this.
Lilly's savings program - Zepbound has a vial program through Lilly for roughly $399/month for self-pay patients.
My Honest Recommendation
Start with an appeal AND check Zepbound coverage simultaneously before going compounded. Compounded is a reasonable backup, but name-brand programs may be more affordable than you think.
Would you like more detail on any of these?